Table 4.

Multivariate analysis of the association between 25-hydroxyvitamin D and metabolic syndrome and its individual components^*

^*Adjusted for age, gender, marital status, education level, region, hours of vigorous activity, body mass index, calcium, creatinine, parathyroid hormone, and magnesium levels

+Central obesity (defined as waist circumference ≥ 94cm for men and ≥ 80cm for women, with ethnicity specific values for other groups) plus any two of the following four factors: 1. Raised triglycerides level: ≥ 150 mg/dL (1.7 mmol/L), or specific treatment for this lipid abnormality, 2. Reduced HDL cholesterol: < 40 mg/dL (1.03 mmol/L) in males and < 50 mg/dL (1.29 mmol/L) in females, or specific treatment for this lipid abnormality, 3. Raised blood pressure: systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg, or treatment of previously diagnosed hypertension, 4. Raised fasting plasma glucose (FPG) ≥ 100 mg/dL (5.6 mmol/L), or previously diagnosed type 2 diabetes